Document is current
Any future updates will be listed below
-
Authors
Weninger, Wolfgang
- License Information
-
More Information
Article History
Accepted: 20 August 2025
First Online: 23 September 2025
Interessenkonflikt
: W. Weninger erhielt Vortrags- und/oder Beratungshonorare von LEO Pharma, dem Hersteller von Delgocitinib.
Free to read: This content has been made available to all.
